PSA Agenda

Wednesday Evening, September 29; 6:00-8:00 pm--Cocktail Reception & Registration; The Plaza Hotel

Thurs., Sep. 30	Grand Ballroom
7:00-8:25 am	Registration and Continental Breakfast
8:30-8:40 am	Opening Remarks, David Cassak, Managing Partner, Windhover Information
8:45-9:45 am	Buy-Siders’ Roundtable David Cassak, Windhover Information; Steve Dalton, Senior Vice President, First Capital; Sandra Panem, Former President, Vector Fund; Paul Brooke, Managing Director, Tiger Management; Larry Feinberg, General Partner, Oracle Partners
9:50-10:20 am	After the Gold Rush: Thoughts on the Future of the Emerging Biopharmaceutical Industry Gary Pinkus, McKinsey & Company
10:20-10:50 am	Coffee Break
10:50-12:20 pm	Financing Biotechnology through Consolidation A Consolidationist: Richard Pops, CEO, Alkermes Been There, Done That: Patrick Mahaffey, former CEO, NeXstar Distress Sales & Mergers from Strength--a VC Point of View: Jeremy Curnock Cook, Merlin Biosciences
12:20-1:30 pm	Lunch
1:35-3:05 pm	Outsourcing and Financing Financing Development: Ludo Reynders, CEO, Quintiles Product Development Financing a Sales Force: Charles Saldarini, President, Professional Detailing Distress Sales & Mergers from Strength -- a VC Point of View: Jon Court, CEO, Fulcrum Pharma Development
3:05-3:25 pm	Coffee Break
3:30-5:00 pm	Biotech’s Most Innovative Deals Strategic JVs as Means of Growing Pharma Cos: Mike Sember, Exec. V.P., Business Development, Elan M&A as Strategy for Broadening Tech. Portfolio: David Greenwood, CFO, Geron Alternatives for Late Stage Deals: Louis Lange, CEO, CV Therapeutics
5:45-8:00 pm	Cocktail Reception - Tavern on the Green
Fri., Oct. 1	Grand Ballroom
7:30-8:15 am	Registration and Continental Breakfast
8:15-9:15 am	Financing the Pharmaceutical Industry: A Roundtable on the Effects of the FASB & SEC Changes Fred Frank, Vice Chairman, Lehman Brothers; Bill Reardon, Partner, PricewaterhouseCoopers; Peter Wirth, EVP, Chief Legal Officer, Genzyme
9:20-10:50 am	Financing the Industry: The External Environment What's Likely with Drug Pricing? Fred Teitelbaum, V.P., Express Scripts The Internet Revolution: Rajesh Garg, McKinsey & Company The Distributor as Pharma Player: Tim Wright, SVP, Bus. Dev., Cardinal Health
10:50-11:15 am	Coffee Break
11:20-11:50 pm	Deals in Review Roger Longman, Managing Partner, Windhover Information
11:50-12:50 pm	Financing the Pharmaceutical Industry: Consolidation and Productivity What we did to improve our productivity: Goran Ando, EVP & President, R&D, Pharmacia & Upjohn What we will do to improve our productivity: Wendell Wierenga, SVP, WW Pharmaceutical Sciences, Technologies & Development, Parke-Davis
12:50-2:00 pm	Luncheon
2:00 - 3:00 pm	Finding New Products: Internal, External or False Dichotomy? David Barry, Chairman & CEO, Triangle Pharmaceuticals; Arthur J. Higgins, President, Pharmaceutical Products Division, Abbott Laboratories
3:00 pm	Closing Remarks